EMERYVILLE, Calif., Feb. 6, 2025 /PRNewswire/ — Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial stage biopharmaceutical company developing and commercializing innovative vaccines, will report fourth quarter and full year 2024 financial results on Thursday, February 20,…
